Amgen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€247.25
Target price
02.05.26
€283.33
Performance (%)
15.77%
Price
15:45
€279.10
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 15.77%. A total of €7.14 was paid as dividends for this prediction. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.215% | 0.215% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $324.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat